What are the factors contributing to failure in improvement of subjective symptoms following silodosin administration in patients with benign prostatic hyperplasia? Investigation using a pressure-flow study.
Phase of Trial: Phase IV
Latest Information Update: 15 Oct 2015
At a glance
- Drugs Silodosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 15 Oct 2015 New trial record